when to increase glp 1 dose GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide How often do you take

Eating below this level consistently leads to muscle loss, metabolic adaptation, and chronic fatigue

A., Fearon, C

Recent Industry Developments FDA Approval of Oral Wegovy and Orforglipron (Regulatory): On December 22, 2025, the FDA approved the first oral GLP-1 specifically for chronic weight management (the Wegovy pill), which launched in January 2026

Zepbound: $349 for the initial dose, then $499 per month for maintenance doses

Of these two drugs, only orlistat was approved for long term use

Transdermal systems may: Provide a needle-free alternative Be easier to use for those with needle aversion Potentially maintain more stable drug levels over time However, it's important to note that the effectiveness and safety of GLP-1 patches have not yet been evaluated in human clinical trials